These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20857816)

  • 41. A nomenclature system for metabolic gene polymorphisms.
    Garte S; Crosti F
    IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed polyvinyl chloride workers.
    Wong RH; Du CL; Wang JD; Chan CC; Luo JC; Cheng TJ
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):475-82. PubMed ID: 12010862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use.
    Lazarus P; Sheikh SN; Ren Q; Schantz SP; Stern JC; Richie JP; Park JY
    Carcinogenesis; 1998 Mar; 19(3):509-14. PubMed ID: 9525287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers.
    Sikdar N; Paul RR; Roy B
    Int J Cancer; 2004 Mar; 109(1):95-101. PubMed ID: 14735473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.
    Wadelius M; Autrup JL; Stubbins MJ; Andersson SO; Johansson JE; Wadelius C; Wolf CR; Autrup H; Rane A
    Pharmacogenetics; 1999 Jun; 9(3):333-40. PubMed ID: 10471065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral cancer and polymorphism of ethanol metabolising genes.
    Marichalar-Mendia X; Rodriguez-Tojo MJ; Acha-Sagredo A; Rey-Barja N; Aguirre-Urizar JM
    Oral Oncol; 2010 Jan; 46(1):9-13. PubMed ID: 19896412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms.
    Sugimura T; Kumimoto H; Tohnai I; Fukui T; Matsuo K; Tsurusako S; Mitsudo K; Ueda M; Tajima K; Ishizaki K
    J Oral Pathol Med; 2006 Jan; 35(1):11-8. PubMed ID: 16393248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer.
    Martone T; Vineis P; Malaveille C; Terracini B
    Mutat Res; 2000 Apr; 462(2-3):303-9. PubMed ID: 10767640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
    Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I
    Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects.
    Drummond SN; Gomez RS; Motta Noronha JC; Pordeus IA; Barbosa AA; De Marco L
    Oral Oncol; 2005 May; 41(5):515-9. PubMed ID: 15878757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
    Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
    Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
    Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus.
    Lee JM; Lee YC; Yang SY; Shi WL; Lee CJ; Luh SP; Chen CJ; Hsieh CY; Wu MT
    Int J Cancer; 2000 Sep; 89(5):458-64. PubMed ID: 11008209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in xenobiotic conjugation and disease predisposition.
    Brockmöller J; Cascorbi I; Kerb R; Sachse C; Roots I
    Toxicol Lett; 1998 Dec; 102-103():173-83. PubMed ID: 10022251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
    Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
    Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetic polymorphism (sequence variation) of foreign substance-metabolizing enzymes and their significance in environmental medicine. Statement of the Commission "Methods and Quality Assurance in Environmental Medicine"].
    Commission on Methods and Quality Assurance in Environmental Medicine
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Nov; 47(11):1115-23. PubMed ID: 15549207
    [No Abstract]   [Full Text] [Related]  

  • 60. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
    Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.